These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4806428)

  • 1. Study of phonocardiographic and apex cardiographic abnormalities in hypertensive disease and their responsiveness to alpha-methyldopa.
    Strausz I; Kékes E; Horányi P; Barcsák J
    Ther Hung; 1973; 21(3-4):97-100. PubMed ID: 4806428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiocirculatory function in hypertensive pregnancy treated with alpha-methyldopa].
    Cellina G; Lo Cicero G; Barbato M; Montanari C; Brina A
    Minerva Cardioangiol; 1980 Oct; 28(10):683-5. PubMed ID: 7465060
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 5. [Excretion of alpha-methylnoradrenaline in the urine of hypertensive patients during treatment with alpha-methyldopa].
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):44-5. PubMed ID: 4231857
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of the blood pressure curve during the ergometric stress test, in treated and non-treated hypertensive patients].
    Carrasco RM; da Rocha MM; Luna RL
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():24-32. PubMed ID: 7325860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of alpha-methyldopa in single and divided doses on the circadian rhythm of arterial pressure in hypertensive patients].
    Carpentiere G; Castello F; Marino S
    Clin Ter; 1984 Mar; 108(6):497-502. PubMed ID: 6233068
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulatory changes during and after surgical anesthesia in hypertensive patients treated with clonidine, methyldopa and reserpine.
    Ryhänen P; Hanhela R; Jouppila R; Vuopala U
    Int Surg; 1984; 69(1):29-33. PubMed ID: 6735626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 10. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS
    Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phono-mechano-cardiographic assessment in hypertensive heart disease: value of the apex cardiographic parameters (author's transl)].
    Nardelli A; Palamara A; Mazzei F; de Francesco A; Ferraiuolo G
    G Ital Cardiol; 1980; 10(5):494-503. PubMed ID: 7450372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in renal function and electrolyte transport after acute decrease of blood pressure induced by a decarboxylase inhibitor (alpha-methyldopa)].
    Koçak N; Kalkay N; Ozdoğan E
    Turk Tip Cemiy Mecm; 1967; 33(11):671-80. PubMed ID: 5598385
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyldopa: single daily dose versus multiple daily dose.
    Yang C; Gurwich E; Kanada S; Nascimento L
    Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of the phono-mechano-cardiographic examination to the diagnosis of hypertensive cardiopathy].
    Nardelli A; Palamara A; Mazzei F; De Francesco A; Ferraiuolo G
    Boll Soc Ital Cardiol; 1979; 24(6):681-9. PubMed ID: 551801
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methyldopa: study of the antihypertensive and renin-reducing effects at rest and after exercise].
    Sbissa AS; Sbissa LA; Thiesen AL; Zunino JN
    Arq Bras Cardiol; 1981 Sep; 37(3):213-7. PubMed ID: 7052027
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
    Fitz AE; Saunders E
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S85-91. PubMed ID: 6172671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.